Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001031640 | SCV001194946 | likely pathogenic | Familial focal epilepsy with variable foci | 2021-08-12 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exon(s) 8-12 of the DEPDC5 gene. This variant would be expected to be in-frame, preserving the integrity of the reading frame. A similar copy number variant has been observed in individual(s) with clinical features of DEPDC5-related conditions (Invitae). This variant disrupts the p.Phe164 amino acid residue in DEPDC5. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 23542697, 25366275). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |